⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9206724 | 1.00 | — | — | |
| SCHEMBL3716678 | 0.86 | — | — | |
| SCHEMBL1908312 | 0.86 | — | — | |
| SCHEMBL29249548 | 0.83 | L3MBTL1 (0.44) | — | |
| SCHEMBL17087884 | 0.83 | L3MBTL1 (0.44) | — | |
| SCHEMBL16056055 | 0.83 | L3MBTL1 (0.44) | — | |
| SCHEMBL16056056 | 0.83 | L3MBTL1 (0.44) | — | |
| SCHEMBL15820316 | 0.81 | L3MBTL1 (0.47) | — | |
| SCHEMBL1445306 | 0.81 | L3MBTL1 (0.47) | — | |
| SCHEMBL6297129 | 0.81 | L3MBTL1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0540807-B1 | Asymmetric synthesis of 3-substituted furanoside compounds | AMERICAN CYANAMID CO (US) | 1995-12-27 | — | — | EP | claimed |
| US-5296620-A | Hexenol derivatives as intermediates for compounds for treatment of AIDS virus infections | AMERICAN CYANAMID COMPANY (US) | 1994-03-22 | — | — | US | claimed |
| US-5216145-A | Conensation, reduction, epoxidation, ring opening, oxidation, hydrogenation, alcoholysis | AMERICAN CYANAMID COMPANY (US) | 1993-06-01 | — | — | US | claimed |
| EP-0540807-A1 | Asymmetric synthesis of 3-substituted furanoside compounds | AMERICAN CYANAMID COMPANY (US) | 1993-05-12 | — | — | EP | claimed |
| JP-5170782-A | — | — | None | — | — | JP | disclosed |
| CN-114149658-B | Resin composition and low-gummosis prepreg prepared from same | 常熟生益科技有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-114085492-B | Resin composition, prepreg and laminated board thereof | 苏州生益科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20210277275-A1 | CROSSLINKED COATINGS | STEVENS DAVID M (US) | 2021-09-09 | — | — | US | disclosed |
| CN-108350305-A | Hydrogel, preparation and medical device comprising hydrogel-coated electrodes | 朗·里昂 | 2018-07-31 | — | — | CN | disclosed |
| WO-2018106938-A1 | CROSSLINKED COATINGS | PENDANT BIOSCIENCES, INC. (US) | 2018-06-14 | — | — | WO | disclosed |
| WO-2016120890-A1 | AN ENANTIOSELECTIVE PROCESS FOR THE SYNTHESIS OF (2S,4R)-4-HYDROXYPIPECOLIC ACID | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-08-04 | — | — | WO | disclosed |
| US-5866036-A | HIGH POLARIZATION; HIGH SPEED SWITCHES; HIGH BIREFRINGENCE | DISPLAYTECH, INC. (US) | 1999-02-02 | — | — | US | disclosed |
| EP-0540807-B1 | Asymmetric synthesis of 3-substituted furanoside compounds | AMERICAN CYANAMID CO (US) | 1995-12-27 | — | — | EP | disclosed |
| US-5296620-A | Hexenol derivatives as intermediates for compounds for treatment of AIDS virus infections | AMERICAN CYANAMID COMPANY (US) | 1994-03-22 | — | — | US | disclosed |
| JP-H05170782-A | ASYMMETRIC SYNTHESIS OF 3-SUBSTITUTED FURANOSIDE COMPOUND | AMERICAN CYANAMID CO | 1993-07-09 | — | — | JP | disclosed |
| US-5216145-A | Conensation, reduction, epoxidation, ring opening, oxidation, hydrogenation, alcoholysis | AMERICAN CYANAMID COMPANY (US) | 1993-06-01 | — | — | US | disclosed |
| EP-0540807-A1 | Asymmetric synthesis of 3-substituted furanoside compounds | AMERICAN CYANAMID COMPANY (US) | 1993-05-12 | — | — | EP | disclosed |